Schedule 13G ownership disclosure

SATSUMA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 80405P107

Event date: 2022-01-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,885,939
Percent of class
6.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-22-001682
Form type
SC 13G/A
Filer
Satsuma Pharmaceuticals, Inc.
CIK
CIK 1692830
Filed
Feb 11, 2022
Reporting period
Jan 12, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub